TOI (The Oncology Institute) Short Ratio


TOI The Oncology Institute Inc TOI
61 GF Score
Price $5.28
GF Value $2.25
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is The Oncology Institute Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

TOI
61GF Score
The Oncology Institute Inc TOI
Short Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is The Oncology Institute (TOI) Overvalued in 2026?

Based on GuruFocus' analysis, The Oncology Institute stock appears to be overvalued. The current stock price of $5.28 is trading 134.7% above its estimated GF Value™ of $2.25. GuruFocus considers The Oncology Institute to be Significantly Overvalued.

Key valuation signals for TOI:

  • Short Ratio:
  • GF Value™: $2.25 vs. price of $5.28 (134.7% above fair value)
  • GF Score™: 61/100 with 6 warning signs

No single metric tells the full story. See the TOI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

The Oncology Institute Business Description

Address 18000 Studebaker Road, Suite 800, Cerritos, CA, USA, 90703
The Oncology Institute Inc offers oncology care and treatment services to patients through several clinics located across the United States. It offers services such as infusion chemotherapy, oral drug chemotherapy, hospice and palliative care, autologous stem cell transplants, outpatient blood product transfusions, patient navigator programs, radiation oncology, and others on a fee or value-based model. Additionally, the company enrolls patients in clinical trials, where appropriate. The company has three operating segments: Specialty Pharmacy, Patient Services, and Clinical Trials and Other. Maximum revenue is generated from the Specialty Pharmacy segment, which operates specialty and retail pharmacies providing IV-infused, oral, injectable, and other medications for oncology treatment.
61GF Score

Get the complete analysis for TOI

Short Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.28
Price
$2.25
GF Value